» Articles » PMID: 27716195

Sarcopenia in Daily Practice: Assessment and Management

Abstract

Background: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice.

Methods: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations.

Results: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress.

Conclusions: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.

Citing Articles

Reference values for the appendicular lean muscle index in healthy young Saudi women: a nutritional perspective.

Alhussain M, Alamro S, Alghannam A, Alabdullatif R, Alkahtani S Front Nutr. 2025; 12:1510432.

PMID: 40046761 PMC: 11879801. DOI: 10.3389/fnut.2025.1510432.


An Attention-Aware Multi-Task Learning Framework Identifies Candidate Targets for Drug Repurposing in Sarcopenia.

Reza M, Qiu C, Lin X, Su K, Liu A, Zhang X J Cachexia Sarcopenia Muscle. 2025; 16(2):e13661.

PMID: 40045692 PMC: 11883102. DOI: 10.1002/jcsm.13661.


Body composition analysis using CT at three aspects of the lumbar third vertebra and its impact on the diagnosis of sarcopenia.

Yang H, Gao Z, Shen Q, Zhi H, Cai W, Wang X World J Surg Oncol. 2025; 23(1):64.

PMID: 40012042 PMC: 11863840. DOI: 10.1186/s12957-024-03634-9.


Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors.

Oztop H, Hunutlu F, Ekizoglu S, Gul O, Cander S, Sahin A J Clin Med. 2025; 14(4).

PMID: 40004836 PMC: 11856822. DOI: 10.3390/jcm14041306.


Does sarcopenia have a negative impact on the efficacy of botulinum toxin A in the prehabilitation of patients undergoing incisional hernia repair? A multicentric retrospective study.

Villemin A, Delorme T, Ortega-Deballon P, Alsuwaidan H, Moszkowicz D, Romain B Hernia. 2025; 29(1):104.

PMID: 39966265 DOI: 10.1007/s10029-025-03291-1.


References
1.
Rizzoli R, Stevenson J, Bauer J, van Loon L, Walrand S, Kanis J . The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014; 79(1):122-32. DOI: 10.1016/j.maturitas.2014.07.005. View

2.
Finger D, Goltz F, Umpierre D, Meyer E, Rosa L, Schneider C . Effects of protein supplementation in older adults undergoing resistance training: a systematic review and meta-analysis. Sports Med. 2014; 45(2):245-55. DOI: 10.1007/s40279-014-0269-4. View

3.
Visser M, Schaap L . Consequences of sarcopenia. Clin Geriatr Med. 2011; 27(3):387-99. DOI: 10.1016/j.cger.2011.03.006. View

4.
Dam T, Peters K, Fragala M, Cawthon P, Harris T, McLean R . An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014; 69(5):584-90. PMC: 3991139. DOI: 10.1093/gerona/glu013. View

5.
Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E . Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012; 31(5):652-8. DOI: 10.1016/j.clnu.2012.02.007. View